Qualys, Inc. (QLYS) is rated a buy, trading at a discount despite strong catalysts for growth acceleration and improving fundamentals. QLYS is driving growth through deeper platform adoption, a partner-first model, flexible pricing, and FedRAMP High authorization, enhancing its competitive position. Shares trade at just 20x NTM PE, well below historical averages and peers, offering a favorable risk/reward profile if growth reaccelerates.

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

Applied Materials sees DRAM-driven momentum with record etch revenues, AI-fueled demand, and growth opportunities in advanced memory.

NEW YORK, NY / ACCESS Newswire / September 18, 2025 / For years, recycling has been built on promises. Promises that systems would scale, that quality would hold, that recycled materials could replace virgin ones without compromise.

KSS drives growth with Sephora partnership, Impulse rollout and stronger digital sales, boosting its position in beauty and accessories.

TJX shows resilient comparable sales and upgraded guidance, while long-term momentum hinges on expansion gains offsetting currency and margin pressures.

Moelis & Co. shares surge 33.5% in three months, fueled by M&A momentum, diversification efforts and strong capital returns.

Micron Technology's AI-driven memory surge and Marvell Technology's custom silicon growth highlight two distinct semiconductor plays.

Live sports streaming is becoming integral to The Trade Desk's CTV push, offering advertisers precision targeting during peak moments.

PPG introduces HI-GARD Non-Methanol coating for ophthalmic lenses, aligning with regulations while boosting safety and sustainability.

Netskope made its Nasdaq debut on Thursday. The company, which trades under the ticker symbol "NTSK," priced shares at $19.

Shares of Netskope rose over 21% in their debut on Nasdaq on Thursday, giving the cybersecurity firm a market capitalization of $8.79 billion.

Pre-market futures are up to start the first trading session since the Fed lowered interest rates 25 basis points (bps) yesterday. New data out this morning sees futures rolling off their early tops, but ultimately the reports are good.

The Medical-HMO industry benefits from strength in commercial plans, M&A and expected Medicare rate hikes, but rising costs, regulatory shifts and workforce shortages strain margins. CI and HUM are likely to navigate industry storms.

Modine's acquisitions, growth outlook, and strong ROE stack up against Gentherm's new awards and China push in the thermal management race.

Even with EV credit sunsets, tariff pressures and tight supply, BLBD and XOS show growth and stand tall in the struggling Domestic Auto industry.

EG expands globally, strengthens its balance sheet, and grows steadily, though ROE still trails industry peers.

The iShares MSCI China Small-Cap ETF (ECNS) offers exposure to Chinese small caps but suffers from high volatility, poor tracking capabilities, and significant underperformance. ECNS's annual turnover and volatility are much higher than typical ETFs, and its sector allocation leans heavily toward low-growth healthcare stocks. Despite a decent 4% yield and a significant valuation discount to peers, ECNS's risk-adjusted returns lag both Chinese large-caps and EM small-caps.

Old guard high-yield corporate bond ETFs have plenty of fans among advisors and fixed income investors. That's understandable because those funds, usually passively managed, provide broad exposure to junk-rated debt, often with favorable fees.

Steven Orr, CEO & founder of Quasar Markets, explains why Nvidia's new partnership with Intel is such a strategic play. Transcript: CAROLINE WOODS: Joining me now, Steven Orr, founder and CEO of Quasar Markets.